kaolinite has been researched along with Burns* in 5 studies
5 other study(ies) available for kaolinite and Burns
Article | Year |
---|---|
Evaluation of topical therapy with silver-kaolin (Argostop) in an experimental model of burn wound sepsis.
Burn wound therapy with silver-kaolin, a topical agent applied as an aerosol spray, was evaluated in male rats given a 20 per cent total body surface area, full thickness dorsal scald burn. Burn wounds treated with silver-kaolin healed at rates comparable to untreated wounds. No significant differences were noted in the numbers or types of organisms colonizing the wounds of treated and untreated rats at 5, 12 and 19 days post-burn. To evaluate the effectiveness of silver-kaolin in treating burn wound sepsis, rats were inoculated on the wound surface with 2.5 x 10(8) Pseudomonas aeruginosa. This inoculum resulted in 100 per cent mortality in untreated rats. Rats treated with silver-kaolin had a mortality rate of 71 per cent, compared to a 9 per cent mortality rate in rats treated with 1 per cent silver sulphadiazine. When silver-kaolin was applied to the wound prior to bacterial inoculation, the mortality rate was reduced to 6 per cent. When wounds were treated with kaolin alone and then inoculated with bacteria, the mortality rate was 50 per cent, indicating that part of the effectiveness of silver-kaolin appeared to be due to a barrier effect. These results indicate that silver-kaolin may be useful for preventive topical antimicrobial therapy of acute burns or after wound debridement or excision, but is not suitable for therapy of wounds previously colonized by microorganisms. Topics: Administration, Topical; Animals; Burns; Disease Models, Animal; Drug Combinations; Kaolin; Male; Pseudomonas Infections; Rats; Rats, Inbred Strains; Silver; Wound Healing; Wound Infection | 1987 |
Hematologic changes following burns.
Topics: Adult; Blood Coagulation Tests; Burns; Complement C3; Complement C4; Factor XII; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Illinois; Kallikreins; Kaolin; Middle Aged; Plasminogen; Prognosis | 1977 |
[Effect of an polyvalent proteinase inhibitor on experimental inflammations].
Topics: Animals; Anti-Inflammatory Agents; Burns; Dextrans; Edema; Female; Formaldehyde; Kallikreins; Kaolin; Male; Protease Inhibitors; Rats | 1971 |
Anti-inflammatory properties of alkyl-pseudothioureas with antibacterial and antifungal activity.
Topics: Acetylcholine; Administration, Topical; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antifungal Agents; Arthritis; Arthrodermataceae; Bacteria; Blood Pressure; Burns; Candida; Candidiasis; Carrageenan; Depression, Chemical; Dextrans; Gastrointestinal Motility; Guinea Pigs; Hindlimb; Kaolin; Mice; Rabbits; Rats; Staphylococcal Infections; Thiourea | 1971 |
[Effect of fresh and burned kaolin on the lungs and peritoneum of rats].
Topics: Aluminum Silicates; Animals; Burns; Kaolin; Lung; Peritoneum; Rats | 1958 |